A role for the receptor tyrosine kinase, Axl, in squamous cell carcinoma invasion and survival

A role for the receptor tyrosine kinase, Axl, in squamous cell carcinoma invasion and survival

Detalhes bibliográficos
Principais autores:	Papadakis, E, Vyas, J, Storey, A, O'Toole, E
Formato:	Conference item
Publicado em:	2008

Registros relacionados

A role for the receptor tyrosine kinase, Axl, in cutaneous squamous cell carcinoma survival
por: Papadakis, E, et al.
Publicado em: (2008)

An antiapoptotic role for the receptor tyrosine kinase Axl in cutaneous squamous cell carcinoma
por: Papadakis, E, et al.
Publicado em: (2009)

A role for the receptor tyrosine kinase Axl in regulating NF-kappa B activity in cutaneous squamous cell carcinomas
por: Papadakis, E, et al.
Publicado em: (2009)

Axl promotes cutaneous squamous cell carcinoma survival through negative regulation of pro-apoptotic Bcl-2 family members.
por: Papadakis, E, et al.
Publicado em: (2011)

The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer.
por: Diana J Uribe, et al.
Publicado em: (2017-01-01)

Axl receptor tyrosine kinase is a regulator of apolipoprotein E
por: Wenchen Zhao, et al.
Publicado em: (2020-05-01)

AXL receptor tyrosine kinase as a therapeutic target in NSCLC
por: Okimoto RA, et al.
Publicado em: (2015-04-01)

Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma
por: Kristina Breitenecker, et al.
Publicado em: (2023-09-01)

AXL receptor tyrosine kinase modulates gonadotropin-releasing hormone receptor signaling
por: Pardis Mohammadzadeh, et al.
Publicado em: (2023-10-01)

AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity
por: Edward T Schmid, et al.
Publicado em: (2016-06-01)

Exosome‐transmitted linc00852 associated with receptor tyrosine kinase AXL dysregulates the proliferation and invasion of osteosarcoma
por: Qiming Li, et al.
Publicado em: (2020-09-01)

Mechanisms of increased invasion of cutaneous squamous cell carcinoma with loss of type VII collagen
por: Martin, V, et al.
Publicado em: (2008)

Signaling Pathways of AXL Receptor Tyrosine Kinase Contribute to the Pathogenetic Mechanisms of Glioblastoma
por: Alberto Repici, et al.
Publicado em: (2024-02-01)

509 Potent and selective inhibition Of AXL receptor tyrosine kinase for the treatment of cancer
por: Matthew Walters, et al.
Publicado em: (2020-11-01)

Molecular analysis of alternative transcripts of equine AXL receptor tyrosine kinase gene
por: Jeong-Woong Park, et al.
Publicado em: (2017-10-01)

Mechanisms of increased invasion of cutaneous squamous cell carcinoma cells with loss of type VII collagen
por: Martins, V, et al.
Publicado em: (2009)

The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer
por: Yeo, Xun Hui, et al.
Publicado em: (2023)

The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer
por: Xun Hui Yeo, et al.
Publicado em: (2023-06-01)

Inhibition of AXL receptor tyrosine kinase enhances brown adipose tissue functionality in mice
por: Vissarion Efthymiou, et al.
Publicado em: (2023-07-01)

The TAM receptor tyrosine kinases Axl and Mer drive the maintenance of highly phagocytic macrophages
por: Lidia Jiménez-García, et al.
Publicado em: (2022-07-01)

AXL receptor tyrosine kinase: a possible therapeutic target in acute promyelocytic leukemia
por: Mariam Fatima, et al.
Publicado em: (2021-06-01)

Targeting of the AXL receptor tyrosine kinase by small molecule inhibitor leads to AXL cell surface accumulation by impairing the ubiquitin-dependent receptor degradation
por: Markus Lauter, et al.
Publicado em: (2019-06-01)

Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinoma
por: Pinato, D, et al.
Publicado em: (2019)

Expression, regulation and targeting of receptor tyrosine kinases in esophageal squamous cell carcinoma
por: Manoj Kumar Kashyap, et al.
Publicado em: (2018-02-01)

Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen.
por: Martins, V, et al.
Publicado em: (2009)

Receptor tyrosine kinases Tyro3, Axl, and Mertk differentially contribute to antibody-induced arthritis
por: Liang Gao, et al.
Publicado em: (2023-08-01)

Altered expression of AXL receptor tyrosine kinase in gastrointestinal cancers: a promising therapeutic target
por: Nataliya Pidkovka, et al.
Publicado em: (2023-07-01)

Immunohistochemical Evaluation and Clinicopathological Correlation of Mer and Axl Tyrosine Kinase TAM Receptors in Cutaneous Melanoma
por: Andrea Pontara, et al.
Publicado em: (2020-04-01)

Loss of type VII collagen in squamous cell carcinoma results in increased invasion with disorganized epithelial differentiation and epithelial-mesenchymal transition
por: Martins, V, et al.
Publicado em: (2008)

Targeting receptor tyrosine kinase signaling: Avenues in the management of cutaneous squamous cell carcinoma
por: Mohan Shankar Gopinatha Pillai, et al.
Publicado em: (2023-06-01)

Correction: Receptor tyrosine kinases Tyro3, Axl, and Mertk differentially contribute to antibody-induced arthritis
por: Liang Gao, et al.
Publicado em: (2023-08-01)

Author Correction: The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer
por: Xun Hui Yeo, et al.
Publicado em: (2023-07-01)

Glycoxidised LDL induced the upregulation of Axl receptor tyrosine kinase and its ligand in mouse mesangial cells.
por: Young Sook Kim, et al.
Publicado em: (2012-01-01)

Cell softening in malignant progression of human lung cancer cells by activation of receptor tyrosine kinase AXL
por: Keisuke Iida, et al.
Publicado em: (2017-12-01)

Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models
por: Pinar Kanlikilicer, et al.
Publicado em: (2017-12-01)

AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications
por: Chenjing Zhu, et al.
Publicado em: (2019-11-01)

Activation of HER3 Interferes with Antitumor Effects of Axl Receptor Tyrosine Kinase Inhibitors: Suggestion of Combination Therapy
por: Robert Torka, et al.
Publicado em: (2014-04-01)

Autocrine signaling by receptor tyrosine kinases in urothelial carcinoma of the bladder.
por: Young H Lee, et al.
Publicado em: (2021-01-01)

Role of Receptor Tyrosine Kinases and Their Ligands in Glioblastoma
por: Estefanía Carrasco-García, et al.
Publicado em: (2014-04-01)

The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression
por: Marie-Anne Goyette, et al.
Publicado em: (2023-12-01)